Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

2022125 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: The Lancet Respiratory Medicine

Volume 10, Issue 10, pp. 972-984

Field-Weighted Citation Impact: 12.34